Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer

Witt, A E, Lee, C-W, Lee, T I, Azzam, D J, Wang, B, Caslini, C, Petrocca, F, Grosso, J, Jones, M, Cohick, E B, Gropper, A B, Wahlestedt, C, Richardson, A L, Shiekhattar, R, Young, R A, Ince, T A·2017·Oncogene
DOI 10.1038/onc.2016.337

Cited by (182)

Items 101–182 of 182

  1. Natural Products Extracted from Fungal Species as New Potential Anti-Cancer Drugs: A Structure-Based Drug Repurposing Approach Targeting HDAC7
    Annalisa Maruca, Roberta Rocca, Raffaella Catalano, Francesco Mesiti, Giosuè Costa, Delia Lanzillotta, Alessandro Salatino, Francesco Ortuso, Francesco Trapasso, Stefano Alcaro et al. · 2020 · Molecules
  2. Manganese Superoxide Dismutase Acetylation and Regulation of Protein Structure in Breast Cancer Biology and Therapy
    Meredith M. Ogle, Rolando Trevino, Joseph R. Schell, Mahboubeh Varmazyad, Nobuo Horikoshi, David R. Gius · 2022 · Antioxidants
  3. Dissimilar tumor cell populations in ascitic fluid of ovarian cancer patients
    Е. В. Кайгородова, N. V. Fedulova, М. О. Очиров, D. A. Dyakov, Sergey V. Molchanov, N. Yu. Chasovskikh · 2020 · Bulletin of Siberian Medicine
  4. The epigenetic regulation of cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence
    Christiana O. Appiah, Manjulata Singh, Lauren May, Ishita Bakshi, Ashish Vaidyanathan, Paul Dent, Gordon D. Ginder, Steven Grant, Harry D. Bear, Joseph W. Landry · 2023 · Advances in cancer research
  5. Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancer
    E. Finnegan, Wei Ding, Ziga Ude, Sara Terer, T. McGivern, Anna M. Blümel, G. Kirwan, Xinxin Shao, F. Genua, Xiao-Fei Yin et al. · 2023 · Cellular Oncology
  6. Suberoylanilide hydroxamic acid-induced specific epigenetic regulation controls Leptin-induced proliferation of breast cancer cell lines
    Xiuyan Feng, Han Han, Dan Zou, Jiaming Zhou, Weiqiang Zhou · 2016 · Oncotarget
  7. Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
    Mafalda Laranjo, Maria João Carvalho, Beatriz Serambeque, André Alves, Carlos Miguel Marto, Isabel Silva, Artur Augusto Paiva, Maria Filomena Botelho · 2020 · Journal of Visualized Experiments
  8. Targeting Epigenetic Dependencies in Solid Tumors: Evolutionary Landscape Beyond Germ Layers Origin
    Francesca Citron, Linda Fabris · 2020 · Cancers
  9. Predictive bioinformatics identifies novel regulators of proliferation in a cancer stem cell model
    Evan Fields, Jonathan D. Wren, Constantin Georgescu, John R. Daum, Gary J. Gorbsky · 2017 · Stem Cell Research
  10. Characteristics of in vitro model systems for ovarian cancer studies
    Patrycja Tudrej, Katarzyna Aleksandra Kujawa, Alexander Jorge Cortez, Katarzyna Marta Lisowska · 2019 · Oncology in Clinical Practice
  11. Targeting Stem Cells in Radiation Oncology
    Robert Paul Coppes, Anna Dubrovska · 2017 · Clinical Oncology
  12. ARID1A deficiency promotes malignant proliferation of hepatocellular carcinoma by activating HDAC7/ENO1 signaling pathway
    Shanshan Zhang, Gang Wu, Lan Shi, Pengsheng Ding, Gan Liu, Wenjiao Chang, Yuanyuan Dai, Xinghua Han, Xiaoling Ma · 2025 · Hepatology Communications
  13. Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites
    Eros Di Giorgio, Roberta Benetti, Emanuela Kerschbamer, Luigi Emilio Xodo, Claudio Brancolini · 2023 · International review of cytology
  14. Histone Deacetylase 7 Gene Overexpression Is Associated with Poor Prognosis of Triple-Negative Breast Cancer Patients
    Bojana Uzelac, Ana Krivokuća, Snežana V. Šušnjar, Zorka Milovanović, Gordana Šupić · 2021 · Genetic Testing and Molecular Biomarkers
  15. The role and application of transcriptional repressors in cancer treatment
    Miso Park, Keon Wook Kang, Ji Won Kim · 2023 · Archives of Pharmacal Research
  16. Analysis of Chromatin Opening in Heterochromatic Non-Small Cell Lung Cancer Tumor-Initiating Cells in Relation to DNA-Damaging Antitumor Treatment
    Mina Eriksson, Petra Hååg, B. Brzozowska, Magdalena Lipka, Halina Lisowska, Rolf Lewensohn, Andrzej Wójcik, Kristina Viktorsson, Lovisa Lundholm · 2017 · International Journal of Radiation Oncology*Biology*Physics
  17. Pan-HDAC inhibitor LAQ824 inhibits the progression of pancreatic ductal adenocarcinoma and suppresses immune escape by promoting antigen presentation
    Yuchen Jia, Jie Li, Wentong Mei, Haoyu Zhang, Zheng Wang, Xiaozhou Xie, Gao Chongchong, Xiaoqing Xu, Fei Li · 2025 · International Immunopharmacology
  18. Role of Histone Deacetylases in the Pathogenesis of Salivary Gland Tumors and Therapeutic Targeting Options
    Maria Manou, Dimitrios S. Kanakoglou, Theodoros Loupis, Dimitrios Miltiadis Vrachnos, Stamatios E Theocharis, Athanasios G. Papavassiliou, Christina Piperi · 2023 · International Journal of Molecular Sciences
  19. Design and evaluation of nanoscale materials with programmed responsivity towards epigenetic enzymes
    Priyanka Ray, Abbas Sedigh, Matthew I. Confeld, Lina Alhalhooly, Kweeni Iduoku, Gerardo M. Casañola‐Martín, Hai Pham‐The, Bakhtiyor Rasulev, Yongki Choi, Zhongyu Yang et al. · 2024 · Journal of Materials Chemistry B
  20. Inhibiting HDAC1 Enhances the Anti-Cancer Effects of Statins through Downregulation of GGTase-Iβ Expression
    Ran Li, Yehua Gan · 2017 · International Journal of Molecular Sciences
  21. Nuclear to Cytoplasmic Transport Is a Druggable Dependency in HDAC7‐driven Small Cell Lung Cancer
    Tingting Qin, Jingya Wang, Jian Wang, Qingwu Du, Liuchun Wang, Hai‐Lin Liu, Wenting Liu, Xueyang Li, Yantao Jiang, Qi Xu et al. · 2025 · Advanced Science
  22. Mechanistic Underpinnings of Epigenetic Enzyme-Responsive Nanoparticles
    Raj Shankar Hazra, Debasmita Dutta, Md Rakib Hasan Khan, Sakurako Tani, Chowdhury S. Abdullah, Naznin Sultana Remex, Richa Aishwarya, Tamjid Islam, Zhongyu Yang, Sanku Mallik et al. · 2025 · ACS Applied Bio Materials
  23. Kinase library screening identifies IGF-1R as an oncogenic vulnerability in intrahepatic cholangiocarcinoma stem-like cells
    Chotirat Rattanasinchai, Panida Navasumrit, Chidchanok Chornkrathok, Mathuros Ruchirawat · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  24. Inhibition of HDAC7 reprograms the histone H3.3 landscape to induce heterochromatin spreading and DNA replication defects in cancer cells
    Ola Hassan, Mattia D. Pizzagalli, Owen P. Leary, John P. Zepecki, Adrianne Corseri, Laura Jinxuan Wu, Shiven Sasipalli, Daniel Lee, Lindsey Hayward, Lily H. Tran et al. · 2025 · Journal of Biological Chemistry
  25. A risk score model based on TGF-β pathway-related genes predicts survival, tumor microenvironment and immunotherapy for liver hepatocellular carcinoma
    Jingsheng Liao, Qi Liu, Jingtang Chen, Zhibin Lu, Huiting Mo, Jun Hua Jia · 2022 · Proteome Science
  26. Effect of histone deacetylase 8 gene deletion on breast cancer cellular mechanism in vitro and in vivo study
    Golebagh Rahmani, Mohammad Raman Moloudi, Razieh Amini, Karim Rahimi, Fardin Fathi, Mohammad Abdi, Rezvan Najafi · 2022 · Life Sciences
  27. Gene network profiling in muscle-invasive bladder cancer: A systematic review and meta-analysis
    Ilaha Isali, Phillip E. McClellan, Adam Christopher Calaway, Megan C. Prunty, Philip H. Abbosh, Kirtishri Mishra, Lee Evan Ponsky, Sarah Coseo Markt, Sarah P. Psutka, Laura Bukavina · 2022 · Urologic Oncology Seminars and Original Investigations
  28. HDAC7 promotes ovarian cancer malignancy via AKT / mTOR signalling pathway
    Qi Feng, Hao Sheng, Xiongxiu Liu, Zhong Yan, Kai Sheng, Yanping Li, Peng Zhang, Xiugui Sheng · 2024 · Journal of Cellular and Molecular Medicine
  29. FBXW7 induces apoptosis in glioblastoma cells by regulating HDAC7
    Xiaohu Nie, Weiqiang Jia, Xiaobin Li, Xuyan Pan, Rui Ming Yin, Ning Liu, Zhongzhou Su · 2021 · Cell Biology International
  30. Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells
    Wen‐Ming Chen, Lu Zhang, Suling Liu, Ceshi Chen · 2022 · Cells
  31. Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment
    Xinyu Li, Cuilian Zhang, Wei Yue, Yuening Jiang · 2024 · Frontiers in Immunology
  32. A Regulative Epigenetic Circuit Supervised by HDAC7 Represses IGFBP6 and IGFBP7 Expression to Sustain Mammary Stemness
    Eros Di Giorgio, Valentina Cutano, Martina Minisini, Vanessa Tolotto, Emiliano Dalla, Claudio Brancolini · 2021 · Epigenomics
  33. Strong Involvement of Classical Histone Deacetylases and Mechanistically Distinct Sirtuins in Bellicose Cancers
    Shabir Ahmad Ganai · 2020 · Springer eBooks
  34. Histone acetylation risk model predicts prognosis and guides therapy selection in glioblastoma: implications for chemotherapy and anti-CTLA-4 immunotherapy
    Xingyi Jin, Zhigang Qin, Hang Zhao · 2024 · BMC Immunology
  35. DFT Study, Linear and Nonlinear Multiple Regression in the Prediction of HDAC7 Inhibitory Activities on a Series of Hydroxamic Acids
    Soro Doh, Lynda Ekou, Bafétigué Ouattara, Mamadou Guy-Richard Koné, Tchirioua Ekou, Nahossé Ziao · 2019 · Computational Molecular Bioscience
  36. Harmine inhibits ovarian cancer migration and invasion and epithelial-mesenchymal transition (EMT) by inhibiting HDAC7 to restore RECK expression
    Yin Bao, Jun Zhu, Xiaoling Mao, Mingyue Zhang, Qiang Ao, Hong Zhu, Jun Gao · 2025 · Biochemical Pharmacology
  37. Molecular mechanisms for sustaining cancer stem cells characteristics and targeted therapeutic strategies
    Chen-xi Zhao, Shuyun Wang, Ke Li · 2026 · Acta Pharmacologica Sinica
  38. Role of Transcription Factor BEND3 and Its Potential Effect on Cancer Progression
    Sarah Naiyer, Lalita Dwivedi, Nishant Singh, Swastik Phulera, Vijay Mohan, Mohammad Zahid Kamran · 2023 · Cancers
  39. Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care
    Shi‐Ming Tu, Jim Zhongning Chen, Sunny R. K. Singh, Ahmet Murat Aydın, Neriman Gökden, Neville N.C. Tam, Yuet‐Kin Leung, Timothy Langford, Shuk‐Mei Ho · 2023 · Cancers
  40. Cancer stem cell plasticity: mechanisms, immune microenvironment crosstalk, and therapeutic implications
    Jingyu Tan, Tao Wen, J S Liu, Xiaoli Ru · 2026 · Journal of Hematology & Oncology
  41. Epigenetics of Breast Cancer
    Manuraj Pandey, Archana Lalwani, Rajendra G. Mehta · 2022 · BENTHAM SCIENCE PUBLISHERS eBooks
  42. Epigenetic factors of green tea consumption in cancer prevention
    László Gy. Szabó, Ferenc Budán, Dávid Szép, Zoltán Gyöngyi, Bence László Raposa, István Kiss · 2024 · Tea in Health and Disease Prevention
  43. Modeling anticancer pharmacophore based on inhibition of HDAC7
    Laboratoire de Thermodynamique et de Physico-Chimie du Milieu, Unité de Formation et de Recherche Sciences Fondamentales et Appliquées, Université Nangui Abrogoua, Abidjan, Côte d’Ivoire, Sopi Thomas Affi, Soro Doh, Souleymane Coulibaly, Bibata Konaté, Nahossé Ziao · 2021 · SDRP Journal of Computational Chemistry & Molecular Modelling
  44. The presence of stem cells in ovarian cancer: a review
    Tricia Dewi Anggraeni, Jenivia Thiono, Intan Winta Pratiwi, Ariananda Hariadi, Tera Dria Kispa, Aria Kekalih, Brahmana Askandar Tjokroprawiro, Lisnawati, Ani Retno Prijanti, Mohamad Farid Aziz et al. · 2023 · Bali Medical Journal
  45. Research Progresses in Cancer Stem Cells of Three Common Fertility-Related Female Malignancies
    Xiping Zhang, Qi-hui Cheng, Hongjian Yang, Enqi Qiao · 2018 · Pathology & Oncology Research
  46. Breast cancer stem cells, epigenetics, and radiation
    Pranela Rameshwar, Garima Sinha, Alejandra I. Ferrer, Yahaira Naaldijk, Caitlyn A. Moore, Qunfeng Wu, Henning Ulrich · 2018 · Journal of Radiation and Cancer Research
  47. HISTONE DEACETYLASES (HDACs) CLASS II GENES AS POTENTIAL DRUG TARGETS IN CANCER
    M Sabeena, Kaiser Jamil, A. V. N. Swamy · 2018 · Journal of Emerging Technologies and Innovative Research
  48. Updates of Role of Stem Cells in Cancer Therapy
    Maged Naser, Mohamed Mn, Lamia H. Shehata · 2022 · International Journal of Progressive Sciences and Technologies
  49. Engineering Approaches in Ovarian Cancer Cell Culture
    Marcin Iwanicki, Tonja Pavlovič, Panteha Behboodi · 2023 · Current cancer research
  50. Signaling mechanisms of chemoresistance in breast cancer stem cells for therapeutics
    Surbhi Shivhare, Amitava Das · 2023 · Elsevier eBooks
  51. Silencing HDAC1 Expression Regulates Extracellular Regulated Protein Kinases/Mitogen-Activated Protein Kinase Signaling Activation and Enhances Chemosensitivity of Ovarian Carcinoma
    Jia Ming Stella Xu, Yan Li, Haixu Wang, Chunlei Qi, Qian Guo, Guoqing Cai, Guyuan Qiao · 2024 · Journal of Biomedical Nanotechnology
  52. Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity
    Qian Dai, Jie Zhu, Jing Yang, Chunyan Zhang, Wenjing Yang, Baishen Pan, Xin‐Rong Yang, Wei Guo, Beili Wang · 2024 · Current Stem Cell Research & Therapy
  53. Additional file 4 of HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway
    Kai Xia Guo, Zhiqiang Ma, Yujiao Zhang, Lu Han, Changjian Shao, Yingtong Feng, Gao, Fei, Shouyin Di, Zhipei Zhang, Jiao Zhang et al. · 2022 · Figshare
  54. Involvement of epigenetic modifications in cancer stem cells and chemoresistance
    Prajakta Oak, Chitra Thakur · 2024 · Elsevier eBooks
  55. A study conducted in breast cancer cells found that (valproic acid) inhibits CIP2A/c-MYC/PI3K/Akt/mTOR signaling molecules and PD-L1
    Elahe Zeinali, Vahid Bagheri, Esmaeil Rostami, Atena Mansouri, Gholamreza Anani Sarab · 2025 · Human Gene
  56. Additional file 3 of A risk score model based on TGF-β pathway-related genes predicts survival, tumor microenvironment and immunotherapy for liver hepatocellular carcinoma
    Liao, Jingsheng, Liu, Qi, Chen, Jingtang, Lu, Zhibin, Huiting Mo, Jia, Jun · 2022 · Figshare
  57. Additional file 1 of Histone acetylation risk model predicts prognosis and guides therapy selection in glioblastoma: implications for chemotherapy and anti-CTLA-4 immunotherapy
    Xingyi Jin, Qin, Zhigang, Hang Zhao · 2024 · Figshare
  58. Additional file 5 of The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos
    RUIQI SHAO, Suzuki, Takayoshi, Mikita Suyama, Yu-ichi Tsukada · 2024 · Figshare
  59. Additional file 2 of A risk score model based on TGF-β pathway-related genes predicts survival, tumor microenvironment and immunotherapy for liver hepatocellular carcinoma
    Liao, Jingsheng, Liu, Qi, Chen, Jingtang, Lu, Zhibin, Huiting Mo, Jia, Jun · 2022 · Figshare
  60. Additional file 2 of The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos
    RUIQI SHAO, Suzuki, Takayoshi, Mikita Suyama, Yu-ichi Tsukada · 2024 · Figshare
  61. Additional file 7 of The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos
    RUIQI SHAO, Suzuki, Takayoshi, Mikita Suyama, Yu-ichi Tsukada · 2024 · Figshare
  62. Additional file 2 of HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway
    Guo, Kai, Zhiqiang Ma, Zhang, Yujiao, Han, Lu, Shao, Changjian, Feng, Yingtong, Gao, Fei, Di, Shouyin, Zhang, Zhipei, Zhang, Jiao et al. · 2022 · Figshare
  63. Additional file 1 of SOX4 maintains the stemness of cancer cells via transcriptionally enhancing HDAC1 revealed by comparative proteomics study
    Liu, Jingshu, Qiu, Jiangfeng, Zhang, Zhiqi, Zhou, Lei, Li, Yunzhe, Ding, Dongyan, Zhang, Yang, Zou, Dongling, Dong Wang, Zhou, Qi et al. · 2021 · Figshare
  64. Additional file 8 of The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos
    RUIQI SHAO, Suzuki, Takayoshi, Mikita Suyama, Yu-ichi Tsukada · 2024 · Figshare
  65. Additional file 1 of Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma
    Reid, Brett M., Vyas, Shraddha, Chen, Zhihua, Chen, Ann, Kanetsky, Peter A., Jennifer B. Permuth, Sellers, Thomas A., Ozlen Saglam · 2021 · Figshare
  66. Additional file 3 of Histone acetylation risk model predicts prognosis and guides therapy selection in glioblastoma: implications for chemotherapy and anti-CTLA-4 immunotherapy
    Xingyi Jin, Qin, Zhigang, Zhao, Hang · 2024 · Figshare
  67. Additional file 12 of The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos
    RUIQI SHAO, Suzuki, Takayoshi, Mikita Suyama, Yu-ichi Tsukada · 2024 · Figshare
  68. Additional file 6 of The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos
    RUIQI SHAO, Suzuki, Takayoshi, Mikita Suyama, Yu-ichi Tsukada · 2024 · Figshare
  69. Additional file 1 of A risk score model based on TGF-β pathway-related genes predicts survival, tumor microenvironment and immunotherapy for liver hepatocellular carcinoma
    Liao, Jingsheng, Liu, Qi, Chen, Jingtang, Lu, Zhibin, Huiting Mo, Jia, Jun · 2022 · Figshare
  70. Additional file 2 of Histone acetylation risk model predicts prognosis and guides therapy selection in glioblastoma: implications for chemotherapy and anti-CTLA-4 immunotherapy
    Xingyi Jin, Qin, Zhigang, Hang Zhao · 2024 · Figshare
  71. Additional file 9 of The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos
    RUIQI SHAO, Suzuki, Takayoshi, Mikita Suyama, Yu-ichi Tsukada · 2024 · Figshare
  72. Additional file 10 of The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos
    RUIQI SHAO, Suzuki, Takayoshi, Mikita Suyama, Yu-ichi Tsukada · 2024 · Figshare
  73. Additional file 1 of HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway
    Guo, Kai, Zhiqiang Ma, Zhang, Yujiao, Han, Lu, Shao, Changjian, Feng, Yingtong, Gao, Fei, Di, Shouyin, Zhang, Zhipei, Zhang, Jiao et al. · 2022 · Figshare
  74. Additional file 1 of The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos
    RUIQI SHAO, Suzuki, Takayoshi, Mikita Suyama, Yu-ichi Tsukada · 2024 · Figshare
  75. Additional file 13 of The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos
    RUIQI SHAO, Suzuki, Takayoshi, Mikita Suyama, Yu-ichi Tsukada · 2024 · Figshare
  76. Additional file 3 of HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway
    Guo, Kai, Ma, Zhiqiang, Zhang, Yujiao, Han, Lu, Shao, Changjian, Feng, Yingtong, Gao, Fei, Di, Shouyin, Zhang, Zhipei, Zhang, Jiao et al. · 2022 · Figshare
  77. Additional file 4 of The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos
    RUIQI SHAO, Suzuki, Takayoshi, Mikita Suyama, Yu-ichi Tsukada · 2024 · Figshare
  78. Additional file 11 of The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos
    RUIQI SHAO, Suzuki, Takayoshi, Mikita Suyama, Yu-ichi Tsukada · 2024 · Figshare
  79. Additional file 3 of The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos
    RUIQI SHAO, Suzuki, Takayoshi, Mikita Suyama, Yu-ichi Tsukada · 2024 · Figshare
  80. Acetylation in ovarian cancer: mechanistic insights into drug resistance and emerging therapeutic opportunities
    Shujie Chen, Qinhong He, Yunxiao He, Jingji Jin, Aiping Wen · 2026 · Journal of Ovarian Research
  81. HDAC1 promotes lung adenocarcinoma progression via the nuclear accumulation of β‑catenin
    Shijie Xu, Xiaolu Chang, Xiayu Wu, Fabao WANG, Jing Xiang, Chaoxiang Lin, He Zhao, Junzhe Li, Xianhua Xu · 2026 · Oncology Reports
  82. BindingDB Entry 50013161: HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates.
    BindingDB · 2022 · UC San Diego